{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:16:26Z","timestamp":1794744986615,"version":"4.9.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":51,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.nicl.2026.103977","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T17:02:05Z","timestamp":1772643725000},"page":"103977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Three-Dimensional quantitative analysis of the Peri-Enhancing zone reveals ADC and CBV signatures of glioblastoma recurrence"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3986-9844","authenticated-orcid":false,"given":"Gergely","family":"Bertalan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolin","family":"Hainc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetan","family":"Paignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona A.","family":"Todea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Kulcsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nicl.2026.103977_b0005","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.nicl.2026.103977_b0010","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2008.19.4969","article-title":"Recurrence Pattern after Temozolomide Concomitant with and Adjuvant to Radiotherapy in newly Diagnosed patients with Glioblastoma: Correlation with Promoter Methylation Status","volume":"27","author":"Brandes","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.nicl.2026.103977_b0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11060-010-0251-4","article-title":"Radiographic patterns of relapse in glioblastoma","volume":"101","author":"Chamberlain","year":"2011","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.nicl.2026.103977_b0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00701-014-2271-x","article-title":"Anatomic features of glioblastoma and their potential impact on survival","volume":"157","author":"Nestler","year":"2015","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.nicl.2026.103977_b0025","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nicl.2026.103977_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15174279","article-title":"Recurrent Glioblastoma: a Review of the Treatment Options","volume":"15","author":"Vaz-Salgado","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.nicl.2026.103977_b0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.nicl.2026.103977_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12050652","article-title":"Supramarginal Resection for Glioblastoma: it is Time to Set Boundaries! a critical Review on a Hot Topic","volume":"12","author":"Guerrini","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.nicl.2026.103977_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061772","article-title":"A Systematic Review and Meta-Analysis of Supramarginal Resection versus Gross Total Resection in Glioblastoma: can we Enhance Progression-Free Survival Time and Preserve Postoperative Safety?","volume":"15","author":"Wach","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.nicl.2026.103977_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109663","article-title":"ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma","volume":"184","author":"Niyazi","year":"2023","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.nicl.2026.103977_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109900","article-title":"Advanced MRI assessment of non-enhancing peritumoral signal abnormality in brain lesions","volume":"143","author":"Martin-Noguerol","year":"2021","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.nicl.2026.103977_b0060","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/neuonc\/nov119","article-title":"Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone","volume":"17","author":"Lem\u00e9e","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.nicl.2026.103977_b0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jnr.25134","article-title":"The peritumoral brain zone in glioblastoma: where we are and where we are going","volume":"101","author":"Giambra","year":"2023","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nicl.2026.103977_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177135","article-title":"Quantitative MRI for analysis of peritumoral edema in malignant gliomas","volume":"12","author":"Blystad","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.nicl.2026.103977_b0075","first-page":"155","article-title":"Diffusion-weighted MRI in neuro-oncology. CNS","volume":"1","author":"Baehring","year":"2012","journal-title":"Oncol"},{"key":"10.1016\/j.nicl.2026.103977_b0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00234-021-02819-3","article-title":"Clinical applications of diffusion-weighted sequence in brain imaging: beyond stroke","volume":"64","author":"Gaddamanugu","year":"2022","journal-title":"Neuroradiology"},{"key":"10.1016\/j.nicl.2026.103977_b0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2214\/AJR.12.9543","article-title":"Perfusion MRI: the five Most frequently asked Technical questions","volume":"200","author":"Essig","year":"2013","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.nicl.2026.103977_b0090","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1148\/radiol.2017170362","article-title":"Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images","volume":"287","author":"Anzalone","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.nicl.2026.103977_b0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11060-025-04991-5","article-title":"Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor","volume":"173","author":"Fares","year":"2025","journal-title":"J Neuro-Oncol"},{"key":"10.1016\/j.nicl.2026.103977_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16162873","article-title":"Risk Factors of distant Recurrence and Dissemination of Wild-Type Glioblastoma: a Single-Center Study and Meta-Analysis","volume":"16","author":"Tsuchiya","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.nicl.2026.103977_b0105","article-title":"RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in adults","volume":"41","author":"Wen","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.nicl.2026.103977_b0110","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.5114\/pjr\/192044","article-title":"The peritumoral brain zone in glioblastoma: a review of the pretreatment approach","volume":"89","author":"Michalska-Foryszewska","year":"2024","journal-title":"Pol. J. Radiol."},{"key":"10.1016\/j.nicl.2026.103977_b0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/RCT.0000000000001386","article-title":"Radiomics-based Machine Learning to Predict Recurrence in Glioma patients using magnetic Resonance Imaging","volume":"47","author":"Hu","year":"2023","journal-title":"J Comput Assist Tomo"},{"key":"10.1016\/j.nicl.2026.103977_b0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12880-025-01853-4","article-title":"Multimodal radiomics in glioma: predicting recurrence in the peritumoural brain zone using integrated MRI","volume":"25","author":"Li","year":"2025","journal-title":"BMC Med. Imaging"},{"key":"10.1016\/j.nicl.2026.103977_b0125","article-title":"Preoperative magnetic Resonance Imaging Radiomics for predicting Early Recurrence of Glioblastoma","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.nicl.2026.103977_b0130","article-title":"Radiomics-based neural network predicts recurrence patterns in glioblastoma using dynamic susceptibility contrast-enhanced MRI","volume":"11","author":"Shim","year":"2021","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.nicl.2026.103977_b0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2214\/AJR.13.11186","article-title":"Gradient of Apparent Diffusion Coefficient Values in Peritumoral Edema helps in Differentiation of Glioblastoma from Solitary Metastatic Lesions","volume":"203","author":"Lemercier","year":"2014","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.nicl.2026.103977_b0140","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3174\/ajnr.A8493","article-title":"Advanced Distance-Resolved Evaluation of the Perienhancing Tumor areas with FLAIR Hyperintensity Indicates Different ADC Profiles by Promoter Methylation Status in Glioblastoma","volume":"46","author":"Bertalan","year":"2025","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.nicl.2026.103977_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fradi.2023.1267615","article-title":"Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integration","volume":"3","author":"Sanvito","year":"2023","journal-title":"Front. Radiol."},{"key":"10.1016\/j.nicl.2026.103977_b0150","article-title":"Clinical applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: recent advances and current challenges","volume":"I","author":"Zhang","year":"2017","journal-title":"Contrast Media Mol"},{"key":"10.1016\/j.nicl.2026.103977_b0155","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/jcbfm.2010.4","article-title":"A fully automated method for quantitative cerebral hemodynamic analysis using DSC-MRI","volume":"30","author":"Bjornerud","year":"2010","journal-title":"J Cerebr Blood F Met"},{"key":"10.1016\/j.nicl.2026.103977_b0160","unstructured":"Foundation, P.S. Python Software Foundation."},{"key":"10.1016\/j.nicl.2026.103977_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fninf.2014.00008","article-title":"Dipy, a library for the analysis of diffusion MRI data","volume":"8","author":"Garyfallidis","year":"2014","journal-title":"Front. Neuroinf."},{"key":"10.1016\/j.nicl.2026.103977_b0170","first-page":"234","article-title":"U-Net: Convolutional Networks for Biomedical image Segmentation","volume":"9351","author":"Ronneberger","year":"2015","journal-title":"Medical Image Computing and Computer-Assisted Intervention, Pt Iii"},{"key":"10.1016\/j.nicl.2026.103977_b0175","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D Slicer as an image computing platform for the Quantitative Imaging Network","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.nicl.2026.103977_b0180","unstructured":"Schroeder W, M.K., Lorensen B. The Visualization Toolkit (VTK), an Open-Source Software System for 3D Computer Graphics, Image Processing, and Visualization. Kitware (2006)."},{"key":"10.1016\/j.nicl.2026.103977_b0185","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00234-004-1246-7","article-title":"Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings","volume":"46","author":"Chiang","year":"2004","journal-title":"Neuroradiology"},{"key":"10.1016\/j.nicl.2026.103977_b0190","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3171\/2016.10.JNS161694","article-title":"Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator","volume":"128","author":"Kolakshyapati","year":"2018","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.nicl.2026.103977_b0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2214\/AJR.10.4752","article-title":"Diagnostic Value of Peritumoral Minimum Apparent Diffusion Coefficient for Differentiation of Glioblastoma Multiforme from Solitary Metastatic Lesions","volume":"196","author":"Lee","year":"2011","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.nicl.2026.103977_b0200","first-page":"937","article-title":"Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors","volume":"24","author":"Lu","year":"2003","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.nicl.2026.103977_b0205","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3174\/ajnr.A2280","article-title":"In Vivo Correlation of Tumor Blood volume and Permeability with Histologic and Molecular Angiogenic Markers in Gliomas","volume":"32","author":"Jain","year":"2011","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.nicl.2026.103977_b0210","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jmri.26580","article-title":"Quantitative histopathologic assessment of perfusion MRI as a marker of glioblastoma cell infiltration in and beyond the peritumoral edema region","volume":"50","author":"Vallatos","year":"2019","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.nicl.2026.103977_b0215","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-09117-4","article-title":"Local detection of microvessels in -wildtype glioblastoma using relative cerebral blood volume: an imaging marker useful for astrocytoma grade 4 classification","volume":"22","author":"Alvarez-Torres","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.nicl.2026.103977_b0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3174\/ajnr.A2743","article-title":"Correlations between Perfusion MR Imaging Cerebral Blood volume, Microvessel Quantification, and Clinical Outcome using Stereotactic Analysis in Recurrent High-Grade Glioma","volume":"33","author":"Hu","year":"2012","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.nicl.2026.103977_b0225","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3174\/ajnr.A2385","article-title":"Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in newly Diagnosed Bevacizumab-Treated Glioblastoma","volume":"32","author":"Pope","year":"2011","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.nicl.2026.103977_b0230","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11060-012-0847-y","article-title":"Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study","volume":"108","author":"Pope","year":"2012","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.nicl.2026.103977_b0235","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/jmri.22304","article-title":"Predicting Survival in Glioblastomas using Diffusion Tensor Imaging Metrics","volume":"32","author":"Saksena","year":"2010","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.nicl.2026.103977_b0240","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11060-014-1636-6","article-title":"Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab","volume":"121","author":"Wen","year":"2015","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.nicl.2026.103977_b0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11060-015-1782-5","article-title":"Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme","volume":"123","author":"Elson","year":"2015","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.nicl.2026.103977_b0250","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1148\/radiol.2521081534","article-title":"Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment","volume":"252","author":"Pope","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.nicl.2026.103977_b0255","doi-asserted-by":"crossref","first-page":"57-+","DOI":"10.2214\/AJR.16.16234","article-title":"Predicting Glioblastoma Recurrence by Early changes in the Apparent Diffusion Coefficient Value and Signal Intensity on FLAIR Images","volume":"208","author":"Chang","year":"2017","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.nicl.2026.103977_b0260","first-page":"835","article-title":"Mean apparent diffusion coefficient values in defining radiotherapy planning target volumes in glioblastoma","volume":"5","author":"Jeong","year":"2015","journal-title":"Quant. Imaging Med. Surg."},{"key":"10.1016\/j.nicl.2026.103977_b0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2176\/nmc.oa.2021-0182","article-title":"Preoperative Apparent Diffusion Coefficient of Peritumoral Lesion associate with Recurrence in patients with Glioblastoma","volume":"62","author":"Matsuda","year":"2022","journal-title":"Neurol. Med. Chir."},{"key":"10.1016\/j.nicl.2026.103977_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30411","article-title":"Predicting glioblastoma recurrence using multiparametric MR imaging of non-enhancing peritumoral regions at baseline","volume":"10","author":"Xing","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.nicl.2026.103977_b0275","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1148\/radiol.2532090007","article-title":"Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging","volume":"253","author":"Barajas","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.nicl.2026.103977_b0280","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11060-016-2300-0","article-title":"Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin","volume":"131","author":"Bennett","year":"2017","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.nicl.2026.103977_b0285","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jon.12247","article-title":"Perfusion MRI in the Evaluation of Suspected Glioblastoma Recurrence","volume":"26","author":"Blasel","year":"2016","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.nicl.2026.103977_b0290","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/0284185112474916","article-title":"Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging","volume":"54","author":"Choi","year":"2013","journal-title":"Acta Radiol."},{"key":"10.1016\/j.nicl.2026.103977_b0295","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1007\/s00330-016-4234-5","article-title":"Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation","volume":"26","author":"Khalifa","year":"2016","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.nicl.2026.103977_b0300","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1148\/radiol.2015151172","article-title":"MR Perfusion-derived Hemodynamic Parametric Response Mapping of Bevacizumab Efficacy in Recurrent Glioblastoma","volume":"279","author":"Kickingereder","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.nicl.2026.103977_b0305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2214\/AJR.17.18003","article-title":"Multiparametric MRI for Differentiation of Radiation Necrosis from Recurrent Tumor in patients with Treated Glioblastoma","volume":"210","author":"Nael","year":"2018","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.nicl.2026.103977_b0310","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1148\/radiol.10091341","article-title":"Glioblastoma: a Method for predicting Response to Antiangiogenic Chemotherapy by using MR Perfusion Imaging-pilot Study","volume":"255","author":"Sawlani","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.nicl.2026.103977_b0315","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3174\/ajnr.A4823","article-title":"Dynamic Susceptibility Contrast-Enhanced MR Perfusion Imaging in Assessing Recurrent Glioblastoma Response to Superselective Intra-Arterial Bevacizumab Therapy","volume":"37","author":"Singh","year":"2016","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.nicl.2026.103977_b0320","first-page":"859","article-title":"Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not","volume":"27","author":"Boxerman","year":"2006","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.nicl.2026.103977_b0325","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1148\/radiol.14131691","article-title":"Outcome Prediction in patients with Glioblastoma by using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor","volume":"272","author":"Jain","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.nicl.2026.103977_b0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3174\/ajnr.A4534","article-title":"Texture Feature Ratios from Relative CBV Maps of Perfusion MRI are Associated with Patient Survival in Glioblastoma","volume":"37","author":"Lee","year":"2016","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.nicl.2026.103977_b0335","first-page":"1081","article-title":"The role of diffusion-weighted imaging in patients with brain tumors","volume":"22","author":"Kono","year":"2001","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nicl.2026.103977_b0340","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2964783","article-title":"Treatment strategies based on Histological Targets against Invasive and Resistant Glioblastoma","volume":"2019","author":"Hara","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.nicl.2026.103977_b0345","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.nicl.2014.09.002","article-title":"Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. a systematic review","volume":"6","author":"Heye","year":"2014","journal-title":"Neuroimage-Clin"},{"key":"10.1016\/j.nicl.2026.103977_b0350","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/19714009231173100","article-title":"Magnetic resonance relaxometry in quantitative imaging of brain gliomas: a literature review","volume":"37","author":"Chekhonin","year":"2024","journal-title":"Neuroradiology Journal"},{"key":"10.1016\/j.nicl.2026.103977_b0355","doi-asserted-by":"crossref","first-page":"3","DOI":"10.18383\/j.tom.2015.00136","article-title":"Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical applications","volume":"1","author":"Liu","year":"2015","journal-title":"Tomography"},{"key":"10.1016\/j.nicl.2026.103977_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42464","article-title":"Systematic review of functional magnetic resonance imaging (fMRI) applications in the preoperative planning and treatment assessment of brain tumors","volume":"11","author":"Abu Mhanna","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.nicl.2026.103977_b0365","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mri.2024.02.008","article-title":"Intravoxel incoherent motion magnetic resonance imaging to assess early tumor response to radiation therapy: Review and future directions","volume":"108","author":"Mesny","year":"2024","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.nicl.2026.103977_b0370","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3174\/ajnr.A6486","article-title":"Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV using Image-Localized Stereotactic Biopsies","volume":"41","author":"Hoxworth","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nicl.2026.103977_b0375","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11060-017-2719-y","article-title":"Normalization of ADC does not improve correlation with overall survival in patients with high-grade glioma (HGG)","volume":"137","author":"Qin","year":"2018","journal-title":"J. Neurooncol"}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158226000367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158226000367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:10:18Z","timestamp":1773407418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158226000367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":75,"alternative-id":["S2213158226000367"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2026.103977","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three-Dimensional quantitative analysis of the Peri-Enhancing zone reveals ADC and CBV signatures of glioblastoma recurrence","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2026.103977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103977"}}